412 related articles for article (PubMed ID: 25293527)
1. Hippo pathway regulation of gastrointestinal tissues.
Yu FX; Meng Z; Plouffe SW; Guan KL
Annu Rev Physiol; 2015; 77():201-27. PubMed ID: 25293527
[TBL] [Abstract][Full Text] [Related]
2. The Hippo pathway in tissue homeostasis and regeneration.
Wang Y; Yu A; Yu FX
Protein Cell; 2017 May; 8(5):349-359. PubMed ID: 28130761
[TBL] [Abstract][Full Text] [Related]
3. Tubule-Specific Mst1/2 Deficiency Induces CKD
Xu C; Wang L; Zhang Y; Li W; Li J; Wang Y; Meng C; Qin J; Zheng ZH; Lan HY; Mak KK; Huang Y; Xia Y
J Am Soc Nephrol; 2020 May; 31(5):946-961. PubMed ID: 32253273
[TBL] [Abstract][Full Text] [Related]
4. The Hippo pathway in intestinal regeneration and disease.
Hong AW; Meng Z; Guan KL
Nat Rev Gastroenterol Hepatol; 2016 Jun; 13(6):324-37. PubMed ID: 27147489
[TBL] [Abstract][Full Text] [Related]
5. Hippo signaling regulates differentiation and maintenance in the exocrine pancreas.
Gao T; Zhou D; Yang C; Singh T; Penzo-Méndez A; Maddipati R; Tzatsos A; Bardeesy N; Avruch J; Stanger BZ
Gastroenterology; 2013 Jun; 144(7):1543-53, 1553.e1. PubMed ID: 23454691
[TBL] [Abstract][Full Text] [Related]
6. Hippo/Yap signaling controls epithelial progenitor cell proliferation and differentiation in the embryonic and adult lung.
Lange AW; Sridharan A; Xu Y; Stripp BR; Perl AK; Whitsett JA
J Mol Cell Biol; 2015 Feb; 7(1):35-47. PubMed ID: 25480985
[TBL] [Abstract][Full Text] [Related]
7. Mst1/2 signalling to Yap: gatekeeper for liver size and tumour development.
Avruch J; Zhou D; Fitamant J; Bardeesy N
Br J Cancer; 2011 Jan; 104(1):24-32. PubMed ID: 21102585
[TBL] [Abstract][Full Text] [Related]
8. The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals.
Zhang N; Bai H; David KK; Dong J; Zheng Y; Cai J; Giovannini M; Liu P; Anders RA; Pan D
Dev Cell; 2010 Jul; 19(1):27-38. PubMed ID: 20643348
[TBL] [Abstract][Full Text] [Related]
9. Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance.
Zhou D; Zhang Y; Wu H; Barry E; Yin Y; Lawrence E; Dawson D; Willis JE; Markowitz SD; Camargo FD; Avruch J
Proc Natl Acad Sci U S A; 2011 Dec; 108(49):E1312-20. PubMed ID: 22042863
[TBL] [Abstract][Full Text] [Related]
10. A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis.
Moroishi T; Park HW; Qin B; Chen Q; Meng Z; Plouffe SW; Taniguchi K; Yu FX; Karin M; Pan D; Guan KL
Genes Dev; 2015 Jun; 29(12):1271-84. PubMed ID: 26109050
[TBL] [Abstract][Full Text] [Related]
11. Large tumor suppressor homologs 1 and 2 regulate mouse liver progenitor cell proliferation and maturation through antagonism of the coactivators YAP and TAZ.
Yi J; Lu L; Yanger K; Wang W; Sohn BH; Stanger BZ; Zhang M; Martin JF; Ajani JA; Chen J; Lee JS; Song S; Johnson RL
Hepatology; 2016 Nov; 64(5):1757-1772. PubMed ID: 27531557
[TBL] [Abstract][Full Text] [Related]
12. The Crosstalk Between Hippo-YAP Pathway and Innate Immunity.
Wang S; Zhou L; Ling L; Meng X; Chu F; Zhang S; Zhou F
Front Immunol; 2020; 11():323. PubMed ID: 32174922
[TBL] [Abstract][Full Text] [Related]
13. The regulation and function of YAP transcription co-activator.
Zhu C; Li L; Zhao B
Acta Biochim Biophys Sin (Shanghai); 2015 Jan; 47(1):16-28. PubMed ID: 25487920
[TBL] [Abstract][Full Text] [Related]
14. Hippo Deficiency Leads to Cardiac Dysfunction Accompanied by Cardiomyocyte Dedifferentiation During Pressure Overload.
Ikeda S; Mizushima W; Sciarretta S; Abdellatif M; Zhai P; Mukai R; Fefelova N; Oka SI; Nakamura M; Del Re DP; Farrance I; Park JY; Tian B; Xie LH; Kumar M; Hsu CP; Sadayappan S; Shimokawa H; Lim DS; Sadoshima J
Circ Res; 2019 Jan; 124(2):292-305. PubMed ID: 30582455
[TBL] [Abstract][Full Text] [Related]
15. YAP and TAZ: a nexus for Hippo signaling and beyond.
Hansen CG; Moroishi T; Guan KL
Trends Cell Biol; 2015 Sep; 25(9):499-513. PubMed ID: 26045258
[TBL] [Abstract][Full Text] [Related]
16. The Hippo Pathway and YAP Signaling: Emerging Concepts in Regulation, Signaling, and Experimental Targeting Strategies With Implications for Hepatobiliary Malignancies.
Werneburg N; Gores GJ; Smoot RL
Gene Expr; 2020 Jun; 20(1):67-74. PubMed ID: 31253203
[TBL] [Abstract][Full Text] [Related]
17. Hippo pathway coactivators Yap and Taz are required to coordinate mammalian liver regeneration.
Lu L; Finegold MJ; Johnson RL
Exp Mol Med; 2018 Jan; 50(1):e423. PubMed ID: 29303509
[TBL] [Abstract][Full Text] [Related]
18. Dual role of YAP and TAZ in renewal of the intestinal epithelium.
Imajo M; Ebisuya M; Nishida E
Nat Cell Biol; 2015 Jan; 17(1):7-19. PubMed ID: 25531778
[TBL] [Abstract][Full Text] [Related]
19. YAP/TAZ-Mediated Upregulation of GAB2 Leads to Increased Sensitivity to Growth Factor-Induced Activation of the PI3K Pathway.
Wang C; Gu C; Jeong KJ; Zhang D; Guo W; Lu Y; Ju Z; Panupinthu N; Yang JY; Gagea MM; Ng PK; Zhang F; Mills GB
Cancer Res; 2017 Apr; 77(7):1637-1648. PubMed ID: 28202507
[TBL] [Abstract][Full Text] [Related]
20. Regulation of Hippo-YAP signaling by insulin-like growth factor-1 receptor in the tumorigenesis of diffuse large B-cell lymphoma.
Zhou X; Chen N; Xu H; Zhou X; Wang J; Fang X; Zhang Y; Li Y; Yang J; Wang X
J Hematol Oncol; 2020 Jun; 13(1):77. PubMed ID: 32546241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
